[Effects of dexamethasone on CTLA-4 expression and apoptosis in lymphocytes obtained from children with mesangial

Feng-Ying Wang1, Si-Guang Lu, Rong-Hua Luo

  • 1Department of Pediatrics, Tai'an City Central Hospital, Tai'an, Shangdong 271000, China. wfy6699@163.com

Abstract

Insights

Children with mesangial proliferative glomerulonephritis (MsPGN) show lower cytotoxic T-lymphocyte antigen-4 (CTLA-4) expression and apoptosis. This suggests CTLA-4 may contribute to MsPGN pathogenesis and glucocorticoid resistance.

Area of Science:

  • Immunology
  • Nephrology
  • Cell Biology

Context:

  • Mesangial proliferative glomerulonephritis (MsPGN) pathogenesis and glucocorticoid (GC) resistance mechanisms remain unclear.
  • Cytotoxic T-lymphocyte antigen-4 (CTLA-4), a T-lymphocyte activation inhibitor, plays a role in immune regulation.

Purpose:

  • To investigate CTLA-4 expression and lymphocyte apoptosis in pediatric MsPGN.
  • To evaluate the effect of dexamethasone (Dex) on CTLA-4 expression and apoptosis in MsPGN lymphocytes.

Summary:

  • Children with MsPGN exhibited significantly lower CTLA-4 expression and apoptosis in lymphocytes compared to healthy controls.
  • Dex treatment did not alter this difference, but a positive correlation between CTLA-4 expression and apoptosis was observed.

Impact:

  • Findings suggest that reduced CTLA-4 expression may be implicated in MsPGN pathogenesis.
  • Abnormal CTLA-4 expression could be a contributing factor to GC resistance in MsPGN.

Related Concept Videos